Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yoo Young Dominique, Lee"'
Autor:
Natalie Plant, Adam Mylonas, Chandrima Sengupta, Doan Trang Nguyen, Shona Silvester, David Pryor, Peter Greer, Yoo Young (Dominique) Lee, Prabhakar Ramachandran, Venkatakrishnan Seshadri, Yuvnik Trada, Richard Khor, Tim Wang, Nicholas Hardcastle, Paul Keall
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background This observational study aims to establish the feasibility of using x-ray images of radio-opaque chemoembolisation deposits in patients as a method for real-time image-guided radiation therapy of hepatocellular carcinoma. Methods
Externí odkaz:
https://doaj.org/article/07eeac21a75e4b139fd0edf1eebed5d1
Autor:
Yoo Young Dominique Lee, Doan Trang Nguyen, Trevor Moodie, Ricky O’Brien, Anne McMaster, Andrew Hickey, Nicole Pritchard, Per Poulsen, Elizaveta Mitkina Tabaksblat, Britta Weber, Esben Worm, David Pryor, Julie Chu, Nicholas Hardcastle, Jeremy Booth, Val Gebski, Tim Wang, Paul Keall
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver
Externí odkaz:
https://doaj.org/article/588e637bf4f3437a99165c6bbd9612f4
Autor:
Andrew Hickey, Anne McMaster, Yoo Young Dominique Lee, Esben S. Worm, Doan Trang Nguyen, Trevor Moodie, Per Rugaard Poulsen, Paul J. Keall, Julie Chu, Nicole Pritchard, Nicholas Hardcastle, Britta Weber, Jeremy T. Booth, Tim Wang, David Pryor, Elizaveta Mitkina Tabaksblat, Ricky O'Brien, Val Gebski
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
Lee, Y Y D, Nguyen, D T, Moodie, T, O’Brien, R, McMaster, A, Hickey, A, Pritchard, N, Poulsen, P, Tabaksblat, E M, Weber, B, Worm, E, Pryor, D, Chu, J, Hardcastle, N, Booth, J, Gebski, V, Wang, T & Keall, P 2021, ' Study protocol of the LARK (TROG 17.03) clinical trial : a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring ', BMC Cancer, vol. 21, no. 1, 494 . https://doi.org/10.1186/s12885-021-08184-x
BMC Cancer
Lee, Y Y D, Nguyen, D T, Moodie, T, O’Brien, R, McMaster, A, Hickey, A, Pritchard, N, Poulsen, P, Tabaksblat, E M, Weber, B, Worm, E, Pryor, D, Chu, J, Hardcastle, N, Booth, J, Gebski, V, Wang, T & Keall, P 2021, ' Study protocol of the LARK (TROG 17.03) clinical trial : a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring ', BMC Cancer, vol. 21, no. 1, 494 . https://doi.org/10.1186/s12885-021-08184-x
Background Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver malignan
Autor:
David N Nolan, Yoo Young Dominique Lee, Alison Szwajcer, Jessica Lee, Peter Graham, Lois Browne, Stacy Cail, Eric Hau, Yaw Chin
Publikováno v:
Journal of Medical Imaging and Radiation Oncology. 58:229-236
Introduction The nipple-areolar complex (NAC) has special histological properties with higher melanocyte concentration than breast skin. To date, there are no data describing the late effects on the NAC following breast-conserving therapy (BCT). This
Autor:
Yoo Young Dominique, Lee, Eric, Hau, Lois H, Browne, Yaw, Chin, Jessica, Lee, Alison, Szwajcer, Stacy, Cail, David N, Nolan, Peter H, Graham
Publikováno v:
Journal of medical imaging and radiation oncology. 58(2)
The nipple-areolar complex (NAC) has special histological properties with higher melanocyte concentration than breast skin. To date, there are no data describing the late effects on the NAC following breast-conserving therapy (BCT). This study evalua